| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-44 |
| filingDate |
2005-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_150f366e28991d58b556baea87e5c679
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd8922ae10488d9337d37cda0af02068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f85180101001463316342cf1b51693b |
| publicationDate |
2006-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1722827-A2 |
| titleOfInvention |
Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy |
| abstract |
This invention relates to new radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy. The radiohalogenated benzamide derivatives according to the invention exhibit novel and especially advantageous properties, in particular with respect to tumor concentration and retardation, liver concentration and blood accumulation. The radiation-therapy doses to be achieved in the tumor, compared to healthy body tissue, are advantageous for the compounds according to the invention. |
| priorityDate |
2004-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |